These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 1193413)
1. [Comparative daily followed clinical study of treatment of chronic pulmonary tuberculosis with various combinations of ethambutol and rifampicin. Daily and intermittent method]. Gruzlica; 1975 Dec; 43(12):1067-98. PubMed ID: 1193413 [No Abstract] [Full Text] [Related]
2. [Comparative clinical evaluation of the treatment of chronic pulmonary tuberculosis with various combinations of ethambutol and rifampicin by the daily and intermittent methods]. Zierski M; Bek E; Bergson H; Kucharska A; Strupczewska-Janusz H Pneumonol Pol; 1977 Apr; 45(4):277-90. PubMed ID: 854460 [No Abstract] [Full Text] [Related]
3. [Treatment of chronic pulmonary tuberculosis with rifampin and ethambutol by the continuous and intermittent methods]. Kotowska M; Zelski S Gruzlica; 1974 May; 42(5):417-9. PubMed ID: 4464230 [No Abstract] [Full Text] [Related]
4. Daily and intermittent short-course regimens in the original treatment of pulmonary tuberculosis. Preliminary results. Cooperative comparative clinical study in Poland. Zierski M Scand J Respir Dis Suppl; 1978; 102():48-52. PubMed ID: 278215 [No Abstract] [Full Text] [Related]
5. [Rifampicin and ethanbutol in daily and intermittent treatment of chronic advanced cavernous pulmonary tuberculosis resistant to many drugs. Preliminary communication. Early results]. Zierski M; Bek E; Kucharska A; Graczyk J; Bukalska Z Gruzlica; 1973 Nov; 41(11):1129-37. PubMed ID: 4765793 [No Abstract] [Full Text] [Related]
6. [Rifampicin combined with ethambutol and other antitubercular drugs in the treatment of patients with pulmonary tuberculosis. Early results. I. Bacteriological evaluation]. Masztalerz J Pneumonol Pol; 1976; 44(1):55-60. PubMed ID: 821043 [No Abstract] [Full Text] [Related]
7. [Therapeutic effect of rifampicin on re-treatment cases of pulmonary tuberculosis. The second study: a study on the combined therapy of rifampicin with ethambutol and pyrazinamide, especially on intermittent therapy]. Kekkaku; 1972 Dec; 47(12):457-66. PubMed ID: 4652424 [No Abstract] [Full Text] [Related]
8. Ambulatory intermittent rifampicin and ethambutol in the retreatment of pulmonary tuberculosis. Sriyabhaya N; Jittinandana A; Kecharanantana P J Med Assoc Thai; 1974 Nov; 57(11):551-7. PubMed ID: 4452812 [No Abstract] [Full Text] [Related]
9. [Effectiveness of rifampin and ethambutol in the treatment of pulmonary tuberculosis]. Gol'dshteĭn VD; Prokhorov EP Probl Tuberk; 1973; 51(12):36-40. PubMed ID: 4782101 [No Abstract] [Full Text] [Related]
10. [Long-term results of treatment with rifampicin and ethambutol in hyperchronic pulmonary tuberculosis with polyresistant bacilli]. Anastasatu C; Sibila S Ftiziologia; 1973; 22(5):477-84. PubMed ID: 4751363 [No Abstract] [Full Text] [Related]
11. [On the effectiveness of rifampicin and ethambutol used in 3 different therapeutical schemes in drug-resistant chronic pulmonary tuberculosis]. Andrian A; Ciobanu V; Cojocaru G; Borşaru I; Ciobanu D; Spirescu G; Roşianu D; Pescariu M Ftiziologia; 1971; 20(6):623-8. PubMed ID: 5162289 [No Abstract] [Full Text] [Related]
12. [Results of treatment of chronically infectious patients with rifampicin in various combinations and in various models]. Górecki R; Stanek S Gruzlica; 1974 May; 42(5):411-6. PubMed ID: 4464229 [No Abstract] [Full Text] [Related]
13. [Organizaton and effectiveness of controlled intermittent outpatient treatment with ethambutol and rifadin in fibro-carvernous pulmonary tuberculosis]. Rudoi NM; Eisaev BA Probl Tuberk; 1975; (1):17-21. PubMed ID: 1144360 [No Abstract] [Full Text] [Related]
14. [Experimental study of schedules for intermittent administration of rifampicin and ethambutol]. Kozulitsyna TI; Petrov IV Probl Tuberk; 1976 May; (5):72-5. PubMed ID: 951412 [No Abstract] [Full Text] [Related]
15. [ rpceedomgs" Intermittent 2-phase regimen in therapy of chronic pulmonary tuberculosis]. Zierski M Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):116-23. PubMed ID: 4491708 [No Abstract] [Full Text] [Related]
16. [Proceedings: Preliminary results of a 2-phase therapy with rifampicin, ethambutol and a third drug in chronic polyresistant tuberculoses]. Neumeyer D; Anschel R; Eule H; Fichtner K; Ganguin HG; Pickroth G Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):135-8. PubMed ID: 4491710 [No Abstract] [Full Text] [Related]
17. [Rifampicin combined with ethambutol and other antitubercular agents in the treatment of patients with chronic pulmonary tuberculosis. Early results. II. Analysis of causes of treatment interruption]. Masztalerz J Pneumonol Pol; 1976 Feb; 44(2):153-61. PubMed ID: 940788 [No Abstract] [Full Text] [Related]
18. [Controlled rifampicin and ethambutol therapy of chronic destructive pulmonary tuberculosis in a rural district]. Stoianovskiĭ EA; Abrarov BA; Iusman ZI; Ganiev AG; Mirzakhalov DK Probl Tuberk; 1976; (8):29-31. PubMed ID: 137403 [No Abstract] [Full Text] [Related]
19. [A comparative study on clinical efficacy of rifampicin (RFP), ethambutol (EB) and ethionamide (1321 TH) in retreatment of pulmonary tuberculosis. Report of the 13th series study part B]. Kekkaku; 1972 May; 47(5):139-44. PubMed ID: 5042532 [No Abstract] [Full Text] [Related]